Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.

A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors significantly improved survival and reduced tumor sizes in animal models ...

Otsuka Pharmaceutical is putting down $33 million cash for a Swedish biotech’s IL1RAP antibodies designed to treat autoimmune and inflammatory diseases. | Otsuka Pharmaceutical is putting down ...

A panelist highlights promising early-phase trial data on trispecific antibodies targeting multiple myeloma antigens and CD3, emphasizing their high response rates, manageable safety profiles, and ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR ...

Based on this mechanism, the researchers developed an innovative bispecific T cell silencer (BiTS) antibody that simultaneously targets LAG-3 and TCR. This antibody selectively regulates ...

Scientists discover llama antibodies that shut down COVID — and its future variants Date: June 16, 2025 Source: Vlaams Instituut voor Biotechnologie Summary: Powerful llama-derived antibodies ...

Another monoclonal antibody, palivizumab (Synagis), is approved for the prevention of RSV, but only in infants ages 6 months and younger who were born prematurely or older infants diagnosed with ...

Infinimmune’s AI Model GLIMPSE-1 Engineers Human-Sourced Antibodies The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season ...

America’s Top Animation Schools Wanna work at Marvel or write the next ‘Flow’? We’ve got the perfect academy for you on THR’s inaugural list.